Download PDF
Thromb Haemost 1994; 72(02): 327-328
DOI: 10.1055/s-0038-1648864
Letter to the Editor
Schattauer GmbH Stuttgart

Repeated Release of the Tissue Factor Pathway Inhibitor

R A S Ariëns
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS, Maggiore Hospital and University of Milan, Italy
,
E M Faioni
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS, Maggiore Hospital and University of Milan, Italy
,
P M Mannucci
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS, Maggiore Hospital and University of Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 01 March 1994

Accepted after revision 19 April 1994

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Sandset PM, Abildgaard U, Larsen ML. Heparin induces release of extrinsic coagulation pathway inhibitor(EPI). Thromb Res 1988; 50: 803-13
    CrossrefPubMedGoogle Scholar
  • 2 Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and characterization ofa cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandemKunitz-type inhibitory domains. J Biol Chem 1988; 263: 6001-6004
    PubMedGoogle Scholar
  • 3 Warr TA, Warn-Cramer BJ, Rao LVM, Rapaport SI. Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiological variables. Blood 1989; 74: 201-206
    PubMedGoogle Scholar
  • 4 Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coag Fibrinol 1992; 3: 439-449
    CrossrefPubMedGoogle Scholar
  • 5 Sandset PM, Abildgaard U, Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI)in plasma and plasma fractions. Thromb Res 1987; 47: 389-400
    CrossrefPubMedGoogle Scholar